Minerva Neurosciences director granted 50,000 options
Minerva Neurosciences, Inc. director G Jan Van Heek received a grant of stock options covering 50,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Minerva Neurosciences, Inc. director G Jan Van Heek received a grant of stock options covering 50,000 shares of common stock. The options have an exercise price of $4.68 per share and expire on June 2, 2036.
The 50,000 options vest in four equal quarterly installments, with one-quarter vesting three months after June 3, 2026 and additional quarters vesting every three months after that. Vesting requires continued service as a non-employee director on each vesting date.
Insider Trade Summary
Grant/Award: 50,000 shares
Grant/Award
1 txn
Insider
VAN HEEK G JAN
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 50,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 50,000 contracts (Direct)
Footnotes (1)
- F1. The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 3, 2026 and an additional 1/4 vesting every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date.
Key Figures
Option grant size: 50,000 options
Exercise price: $4.68 per share
Expiration date: June 2, 2036
+1 more
4 metrics
Option grant size
50,000 options
Stock Option (right to buy) granted to director
Exercise price
$4.68 per share
Conversion or exercise price of stock options
Expiration date
June 2, 2036
Option term end date
Post-grant derivative holdings
50,000 options
Total derivative securities following transaction
Key Terms
Stock Option (right to buy), exercise price, expiration date, non-employee director, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)""
exercise price financial
"conversion_or_exercise_price: "4.6800""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-06-02T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
non-employee director financial
"continued service of the Reporting Person as a non-employee director"
vesting financial
"The shares subject to this option vest in four equal quarterly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Minerva Neurosciences (NERV) disclose in this Form 4?
Minerva Neurosciences reported that director G Jan Van Heek received a grant of stock options for 50,000 shares of common stock. These options were awarded as compensation and are not an open-market purchase or sale of existing shares.
How many Minerva Neurosciences (NERV) options were granted to the director?
The director was granted stock options covering 50,000 shares of Minerva Neurosciences common stock. This entire amount is reflected as derivative securities following the transaction and represents a new compensation award rather than a market trade.
What is the exercise price and expiration date of the NERV stock options?
The granted stock options have an exercise price of $4.68 per share and expire on June 2, 2036. The option holder may exercise vested portions at this fixed price any time before the expiration, subject to plan and service conditions.
How do the Minerva Neurosciences (NERV) director’s options vest?
The 50,000 options vest in four equal quarterly installments. One-quarter vests three months after June 3, 2026, with additional quarters vesting every three months thereafter. Each vesting event requires continued service as a non-employee director on that date.
How many derivative securities does the Minerva Neurosciences (NERV) director hold after this grant?
After this grant, the Form 4 shows the director holding 50,000 derivative securities in the form of stock options. This total corresponds to the newly granted options that can convert into common shares upon exercise, subject to vesting conditions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates